Autoimmune hemolytic anemia
Jump to navigation
Jump to search
In hematology, Autoimmune hemolytic anemia is an "acquired hemolytic anemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red blood cells."[1]
Classification
- Autoimmune hemolytic anemia
- Direct antiglobulin ("Coombs") test-negative
- Direct antiglobulin ("Coombs") test-positive
- Cold agglutinin disease[2]
Diagnosis
- Red-blood-cell-bound immunoglobulin G[3]
- Coombs' test, using the direct method, may have 97% sensitivity for detecting warm antibodies.[4][5]
Treatment
Rituximab, a monoclonal antibody, was found to be safe by a systematic review of 21 studies, although only one was a randomized controlled trials.[6]
References
- ↑ Anonymous (2024), Autoimmune hemolytic anemia (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Berentsen S, Tjønnfjord GE (2012). "Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia.". Blood Rev 26 (3): 107-15. DOI:10.1016/j.blre.2012.01.002. PMID 22330255. Research Blogging.
- ↑ Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E (2009). "Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia.". Am J Hematol 84 (2): 98-101. DOI:10.1002/ajh.21336. PMID 19105232. Research Blogging.
- ↑ Worlledge SM, Blajchman MA (1972). "The autoimmune haemolytic anaemias.". Br J Haematol 23: Suppl:61-9. PMID 4567200. [e]
- ↑ Allgood JW, Chaplin H (1967). "Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965.". Am J Med 43 (2): 254-73. PMID 6034957. [e]
- ↑ Reynaud Q, Durieu I, Dutertre M, Ledochowski S, Durupt S, Michallet AS et al. (2014). "Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.". Autoimmun Rev. DOI:10.1016/j.autrev.2014.11.014. PMID 25497766. Research Blogging.